文献速递甲状腺疾病

法国原位甲状腺儿童中短暂性先天性甲状腺功能减退症的患病率及决定因素:一项回顾性队列研究

Prevalence and Determinants of Transient Congenital Hypothyroidism in Children With Eutopic Gland in France: A Retrospective Cohort Study.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

通过法国国家先天性甲状腺功能减退症登记系统与法国国家健康数据系统概率链接,纳入2006至2012年出生的原位甲状腺儿童,回顾性分析左甲状腺素报销记录以判定短暂性先天性甲状腺功能减退症(TCH)。在471例主样本中,32.9%为TCH,早产、筛查时TSH<50 mU/L、12月龄左甲状腺素剂量、先天性心脏畸形及出生年份与TCH相关。

要点

  • 在471例原位甲状腺先天性甲状腺功能减退症儿童中,32.9%(155例)为短暂性。
  • 早产、筛查时TSH<50 mU/L、先天性心脏畸形及出生年份与短暂性先天性甲状腺功能减退症相关。

核心结论

  • 三分之一的儿童为短暂性先天性甲状腺功能减退症,其与出生时及产后若干特征相关。
  • 这些数据对先天性甲状腺功能减退症的医疗管理和流行病学监测有用。

研究设计与样本

  • 回顾性队列研究,使用概率记录链接将2006至2012年出生的原位甲状腺儿童从法国国家先天性甲状腺功能减退症登记系统与法国国家健康数据系统(SNDS)链接。
  • 登记记录的703名儿童中,484名(68.8%)被链接;主研究样本为471例。
  • 回顾性审查2006年1月1日至2017年12月31日期间口服左甲状腺素(LT4)的报销情况。
  • 在2017年12月31日前停药6个月及以上的儿童被归类为短暂性先天性甲状腺功能减退症。
  • 使用Cox模型分析与短暂性先天性甲状腺功能减退症相关的因素。

主要发现

  • 主研究样本(n=471)中,53.5%为女性,14.2%为早产,13.8%为低出生体重。
  • 四分之一(n=111,24.3%)在诊断时为轻度先天性甲状腺功能减退症(血清促甲状腺激素[TSH]<50 mU/L),治疗开始时左甲状腺素中位剂量为30 μg/天。
  • 三分之一(n=155,32.9%)为短暂性先天性甲状腺功能减退症。
  • 早产(校正风险比=2.1 [1.0-4.2])、筛查时TSH<50 mU/L(7.4 [3.2-17.1])、12月龄时接受的左甲状腺素剂量(0.98 [0.97-0.99,P=0.003])、先天性心脏畸形(6.6 [1.5-29.0])及出生年份(1.2 [1.1-1.4])均与短暂性先天性甲状腺功能减退症相关。

关键数值与推荐

  • 短暂性先天性甲状腺功能减退症定义为在2017年12月31日前停药6个月及以上。
  • 轻度先天性甲状腺功能减退症定义为诊断时血清TSH<50 mU/L。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The increase in the incidence of congenital hypothyroidism (CH) reported worldwide may partly be explained by an increase in the transient form of CH. OBJECTIVE: We aimed to estimate the proportion of transient CH (TCH) in France, and to identify associated neonatal and young child characteristics. METHODS: We used probabilistic record linkage to link children with eutopic gland born between 2006 and 2012 recorded in the national French CH registry and the French national health data system (SNDS). Of the 703 children recorded, 484 (68.8%) were linked. We retrospectively examined reimbursement for oral levothyroxine (LT4) between January 1, 2006, and December 31, 2017. Children who had discontinued treatment for 6 months or more before December 31, 2017, were classified as having TCH. We used a Cox model to examine the factors associated with TCH. RESULTS: Among the main study sample (n = 471), 53.5% were female, 14.2% were preterm, and 13.8% had low birth weight. One-quarter (n = 111, 24.3%) had mild CH (thyroid-stimulating hormone [TSH] < 50 mU/L, serum) at diagnosis and a median LT4 dose at treatment initiation of 30 μg/day. One-third (n = 155, 32.9%) had TCH. Premature birth (adjusted hazard ratio = 2.1 [1.0-4.2]), a TSH < 50 mU/L at CH screening (7.4 [3.2-17.1]), LT4 dose received at 12 months of age (0.98 [0.97-0.99, P = 0.003]), congenital cardiac malformations (6.6 [1.5-29.0]), and year of birth (1.2 [1.1-1.4]) were all associated with TCH. CONCLUSION: One-third of the children had TCH, and it was associated with several characteristics at birth and postpartum. These data are useful for CH medical management and epidemiological surveillance.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Barry Y, Mandereau-Bruno L, Bonaldi C, et al. Prevalence and Determinants of Transient Congenital Hypothyroidism in Children With Eutopic Gland in France: A Retrospective Cohort Study. J Clin Endocrinol Metab. 2022. PMID: 34850038. doi:10.1210/clinem/dgab854

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。